11.07.26 -- Drug Discovery Online Best Of October

This Drug Discovery Live panel explores the scientific, clinical, and commercial forces shaping the next generation of radiopharmaceuticals. Experts will discuss emerging alpha- and beta-emitting therapies, targeting advances, manufacturing challenges, and clinical lessons. Gain insights into underserved opportunities and how to position your pipeline in the rapidly evolving nuclear medicine landscape. Register today for the live session on November 19, 2026, at 11 AM ET!

HHS is advancing human-based drug research through new FDA terminology, NIH infrastructure, CDC studies, and ARPA-H tools that reduce reliance on animal testing.

The AAPS/BioIVT interactive event made NAM adoption feel less like a science debate and more like a trust-building exercise rooted in use cases, standards, and candid exchange.

The autonomous lab is not a distant aspiration but a present-day competitive differentiator.

Gain insight into ELISA fundamentals, data interpretation, and workflow optimization, supported by real lab examples and step‑by‑step guidance to help researchers improve accuracy and reduce variability.

DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.

Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.